Home Haemodialysis Training and Support
Let our education team walk you through the patient journey, industry updates, NxStage products, and the benefits of more frequent home haemodialysis.
The Simply Home programme was designed as a modular training course for both home haemodialysis beginners and experts. Courses can be taken one at a time or given as a full five-module program.
Each module features a range of key topics across the home haemodialysis category.
Simply Home Modules:
- Understanding the patient therapy selection process
- Basic knowledge of home haemodialysis and its barriers
- Home haemodialysis environment
- System One equipment, therapy, and prescribing
- Benefits of more frequent home haemodialysis with System One
- Understanding the different types of learners
- Steps for training success
- Cannulation best practices
- A concise review of selected research
Despite the health benefits that home and more frequent hemodialysis may provide to those with chronic kidney disease, these forms of therapy are not for everyone. Home hemodialysis with the NxStage System One requires a patient and partner who are committed to being trained on and following the guidelines for proper system operation.
The reported benefits of home hemodialysis may not be experienced by all patients.
The NxStage System One is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set.
Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.
Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because therapy is performed while the patient and care partner are sleeping. These risks include, but are not limited to, blood access disconnects and blood loss during sleep, blood clotting due to slower blood flow or increased treatment time or both, and delayed response to alarms when waking from sleep.
Patients should consult their doctor to understand the risks and responsibilities of performing these therapies using the NxStage System.